New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Nemours Children's Health to lead discussion on child health at HLTH

Nemours Children's Health to lead discussion on child health at HLTH

Nemours Children's Health will host the first-ever dedicated pediatric session at HLTH, the leading platform bringing together the entire health ecosystem focused on health innovation and transfor
World medicine November 09,2023
Nemours Children's Health to lead discussion on child health at HLTH

Nemours Children's Health to lead discussion on child health at HLTH

Nemours Children's Health will host the first-ever dedicated pediatric session at HLTH, the leading platform bringing together the entire health ecosystem focused on health innovation and transfor
World medicine November 09,2023
Research opens the door for better use of people's own immune system T cells to fight cancer

Research opens the door for better use of people's own immune system T cells to fight cancer

Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells know
World medicine November 09,2023
Research opens the door for better use of people's own immune system T cells to fight cancer

Research opens the door for better use of people's own immune system T cells to fight cancer

Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells know
World medicine November 09,2023
AI tool PARMESAN predicts drug-gene interactions for genetic disorders

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

To discover new treatments for genetic disorders, scientists need a thorough knowledge of prior literature to determine the best gene/protein targets and the most promising drugs to test. However, bio
World medicine November 09,2023
AI tool PARMESAN predicts drug-gene interactions for genetic disorders

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

To discover new treatments for genetic disorders, scientists need a thorough knowledge of prior literature to determine the best gene/protein targets and the most promising drugs to test. However, bio
World medicine November 09,2023
Metabolism-targeting drug could offer new hope for cancer-related fatigue

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment. For those struggling with CRF, there have been
World medicine November 09,2023
Metabolism-targeting drug could offer new hope for cancer-related fatigue

Metabolism-targeting drug could offer new hope for cancer-related fatigue

Cancer-related fatigue (CRF) is a debilitating yet all-too-common condition, which can severely affect quality of life for patients undergoing treatment. For those struggling with CRF, there have been
World medicine November 09,2023
Robotic device could revolutionize how women monitor their breast health

Robotic device could revolutionize how women monitor their breast health

A device has been created that could carry out Clinical Breast Examinations (CBE).The manipulator, designed by a team at theUniversity of Bristol and based at the Bristol Robotics Laboratory, is
World medicine November 09,2023
Robotic device could revolutionize how women monitor their breast health

Robotic device could revolutionize how women monitor their breast health

A device has been created that could carry out Clinical Breast Examinations (CBE).The manipulator, designed by a team at theUniversity of Bristol and based at the Bristol Robotics Laboratory, is
World medicine November 09,2023
Can viruses in our gut be a game changer for health?

Can viruses in our gut be a game changer for health?

During the COVID-19 pandemic, people became well aware that viruses can be extremely harmful. But can viruses also be helpful?Bryan Hsu aims to find out by studying viruses that infect bacteria in the
World medicine November 09,2023
Can viruses in our gut be a game changer for health?

Can viruses in our gut be a game changer for health?

During the COVID-19 pandemic, people became well aware that viruses can be extremely harmful. But can viruses also be helpful?Bryan Hsu aims to find out by studying viruses that infect bacteria in the
World medicine November 09,2023
Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-genera
World medicine November 09,2023
Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers

Aventa™ Genomics, LLC, a clinical laboratory established as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics Inc., today announced the launch of Aventa FusionPlus, a next-genera
World medicine November 09,2023
Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

A study published in the journalChildrenaddresses the risk factors associated with the use of social media among adolescents and its impact on their overall wellbeing.Study:Healthy S
World medicine November 09,2023
Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

A study published in the journalChildrenaddresses the risk factors associated with the use of social media among adolescents and its impact on their overall wellbeing.Study:Healthy S
World medicine November 09,2023
Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in
World medicine November 09,2023
Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in
World medicine November 09,2023
Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early dete
World medicine November 09,2023
Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Groundbreaking research focuses on brain health monitoring, early detection of neurodegenerative diseases

Associate Professor at the University of Oulu Teemu Myllylä, a leading expert in biomedical engineering, recently discussed his team's groundbreaking work in brain health monitoring and early dete
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com